North Flow SRL
North Flow reported total assets of 303,640 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026).
The score of North Flow shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -97 % Total assets -62 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
North Flow's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 04 Aug 2023
- Year ended 31 Dec 2021filed on 11 Aug 2022
North Flow's financial analysis
- Solvency1.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of North Flow
North Flow's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0429.979.323
- VAT number
- BE0429979323
- Peppol
- Registered · 0208:0429979323 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Dec 1986
- Registered office
- 2018 Antwerp
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
North Flow (SRL) has been based in Antwerp since 1986, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 4,213 € and equity of 4,455 €; its revenue is not published. Its solvency stands at 1.5%, below the median of its sector (44.2%).
Companies similar to North Flow
Companies in the same business, of comparable size and area, outside its group.
- Vroome Pharma Management Retail sale of pharmaceutical products Antwerp · balance sheet 229,894 €
- J&L Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 664,453 €
- Chi-LiVita Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet 340,234 €
- Pharmacie Baron DE Castro Retail sale of pharmaceutical products Etterbeek · balance sheet 285,240 €
- KG Farma Retail sale of pharmaceutical products Leuven · balance sheet 622,811 €
- Decapharma Retail sale of pharmaceutical products Knokke-Heist · balance sheet 291,134 €
- Lidefarma Retail sale of pharmaceutical products Lierde · balance sheet 495,027 €
- JPMA Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 295,815 €
Frequently asked questions about North Flow
What is the revenue of North Flow?
North Flow files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of North Flow?
In Belgium, the VAT number is the company number prefixed with BE: BE0429979323 for North Flow, if the company is VAT-registered. Its company number (CBE) is 0429.979.323.
Where is the registered office of North Flow?
According to the CBE register, the registered office of North Flow is in 2018 Antwerp.
What is the equity of North Flow?
At the close of the 2025 financial year, the equity of North Flow amounts to 4,455 €, a solvency of 1.5% of total assets.
Who manages North Flow?
The register lists 1 active mandates at North Flow. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of North Flow
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →